Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk

S.W. ten Broeke, R.M. Brohet, C.M. Tops, H.M. van der Klift, M.E. Velthuizen, I. Bernstein, G.C. Munar, E.G. Garcia, N. Hoogerbrugge, T.G.W. Letteboer, F.H. Menko, A. Lindblom, A.R. Mensenkamp, P. Moller, T.A. Os, N. Rahner, B.J.W. Redeker, R.H. Sijmons, L. Spruijt, M. SuerinkY.J. Vos, A. Wagner, F.J. Hes, HF Vasen, M. Nielsen, J.T. Wijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)319-325
JournalJournal of Clinical Oncology
Volume33
Issue number4
DOIs
Publication statusPublished - 2015

Cite this